AAAAAA

   
Results: 1-25 |
Results: 25
ITERATIVE COOPERATIVE PROTOTYPING IN THE DESIGN OF WEB-BASED TRANSPLANT INFORMATION-SYSTEMS
Authors: MERION RM LEICHTMAN AB TSUI N DEAN J
Citation: Rm. Merion et al., ITERATIVE COOPERATIVE PROTOTYPING IN THE DESIGN OF WEB-BASED TRANSPLANT INFORMATION-SYSTEMS, Transplantation proceedings, 30(5), 1998, pp. 1634-1636
RENAL-TRANSPLANTATION FOR SYSTEMIC LUPUS ERYTHEMATOSIS - EXCELLENT LONG-TERM RESULTS WITH BOTH LIVING AND CADAVERIC DONORS
Authors: MAGEE JC LEICHTMAN AB MERION RM
Citation: Jc. Magee et al., RENAL-TRANSPLANTATION FOR SYSTEMIC LUPUS ERYTHEMATOSIS - EXCELLENT LONG-TERM RESULTS WITH BOTH LIVING AND CADAVERIC DONORS, Transplantation proceedings, 30(5), 1998, pp. 1798-1799
GADOLINIUM-ENHANCED MAGNETIC-RESONANCE ANGIOGRAPHY OF RENAL-TRANSPLANTS
Authors: JOHNSON DBS LERNER CA PRINCE MR KAZANJIAN SN NARASIMHAM DL LEICHTMAN AB CHO KJ
Citation: Dbs. Johnson et al., GADOLINIUM-ENHANCED MAGNETIC-RESONANCE ANGIOGRAPHY OF RENAL-TRANSPLANTS, Magnetic resonance imaging, 15(1), 1997, pp. 13-20
LONG-TERM RENAL-ALLOGRAFT SURVIVAL - PROGNOSTIC IMPLICATION OF THE TIMING OF ACUTE REJECTION EPISODES
Authors: LEGGAT JE OJO AO LEICHTMAN AB PORT FK WOLFE RA TURENNE MN HELD PJ
Citation: Je. Leggat et al., LONG-TERM RENAL-ALLOGRAFT SURVIVAL - PROGNOSTIC IMPLICATION OF THE TIMING OF ACUTE REJECTION EPISODES, Transplantation, 63(9), 1997, pp. 1268-1272
ROLE OF INTESTINAL P-GLYCOPROTEIN (MDR1) IN INTERPATIENT VARIATION INTHE ORAL BIOAVAILABILITY OF CYCLOSPORINE
Authors: LOWN KS MAYO RR LEICHTMAN AB HSIAO HL TURGEON DK SCHMIEDLINREN P BROWN MB GUO WS ROSSI SJ BENET LZ WATKINS PB
Citation: Ks. Lown et al., ROLE OF INTESTINAL P-GLYCOPROTEIN (MDR1) IN INTERPATIENT VARIATION INTHE ORAL BIOAVAILABILITY OF CYCLOSPORINE, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 248-260
IDENTIFICATION OF THE MAJOR INDEPENDENT RISK-FACTORS FOR ALLOGRAFT-REJECTION, GRAFT LOSS AND DEATH AFTER RENAL-TRANSPLANTATION BY MULTIVARIATE STEPWISE PROPORTIONAL HAZARDS ANALYSIS
Authors: ROSSI SJ ARMSTRONG DR PUNCH JD WAIDLEY MR SCHMOUDER RL BROMBERG JS LEICHTMAN AB MERION RM
Citation: Sj. Rossi et al., IDENTIFICATION OF THE MAJOR INDEPENDENT RISK-FACTORS FOR ALLOGRAFT-REJECTION, GRAFT LOSS AND DEATH AFTER RENAL-TRANSPLANTATION BY MULTIVARIATE STEPWISE PROPORTIONAL HAZARDS ANALYSIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3372-3372
CYCLOSPORINE DOSE, BLOOD-LEVELS, AND RENAL-ALLOGRAFT FUNCTION AFTER CONVERSION FROM SANDIMMUNE TO NEORAL
Authors: SCHMOUDER RL ROSSI SJ HENRY SL LEICHTMAN AB
Citation: Rl. Schmouder et al., CYCLOSPORINE DOSE, BLOOD-LEVELS, AND RENAL-ALLOGRAFT FUNCTION AFTER CONVERSION FROM SANDIMMUNE TO NEORAL, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3378-3378
GENDER DISCREPANCIES IN LIVING-RELATED RENAL-TRANSPLANT DONORS AND RECIPIENTS
Authors: BLOEMBERGEN WE PORT FK MAUGER EA BRIGGS JP LEICHTMAN AB
Citation: We. Bloembergen et al., GENDER DISCREPANCIES IN LIVING-RELATED RENAL-TRANSPLANT DONORS AND RECIPIENTS, Journal of the American Society of Nephrology, 7(8), 1996, pp. 1139-1144
PANCREAS TRANSPLANTATION FOR DIABETES-MELLITUS
Authors: PIRSCH JD ANDREWS C HRICIK DE JOSEPHSON MA LEICHTMAN AB LU CY MELTON LB RAO VK RIGGIO RR STRATTA RJ WEIR MR
Citation: Jd. Pirsch et al., PANCREAS TRANSPLANTATION FOR DIABETES-MELLITUS, American journal of kidney diseases, 27(3), 1996, pp. 444-450
POTENTIAL RENAL DONORS - COMPARISON OF CONVENTIONAL IMAGING WITH HELICAL CT
Authors: PLATT JF ELLIS JH KOROBKIN M REIGE KA KONNAK JW LEICHTMAN AB
Citation: Jf. Platt et al., POTENTIAL RENAL DONORS - COMPARISON OF CONVENTIONAL IMAGING WITH HELICAL CT, Radiology, 198(2), 1996, pp. 419-423
CENTER EFFECT IN LIVING-RELATED DONOR RENAL-TRANSPLANTATION
Authors: OJO AO WOLFE RA HELD PJ PORT FK PAREKH RS LEICHTMAN AB
Citation: Ao. Ojo et al., CENTER EFFECT IN LIVING-RELATED DONOR RENAL-TRANSPLANTATION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1109-1109
CHOLESTEROL EMBOLI PRESENTING AS ACUTE ALLOGRAFT DYSFUNCTION AFTER RENAL-TRANSPLANTATION
Authors: SINGH I KILLEN PD LEICHTMAN AB
Citation: I. Singh et al., CHOLESTEROL EMBOLI PRESENTING AS ACUTE ALLOGRAFT DYSFUNCTION AFTER RENAL-TRANSPLANTATION, Journal of the American Society of Nephrology, 6(2), 1995, pp. 165-170
IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 3A IN NORMAL AND NEOPLASTIC KIDNEY AND URINARY-BLADDER EPITHELIUM
Authors: LEGGAT JE JOHNSON KJ KOLARS JC SCHMIEDLINREN P WATKINS PB LEICHTMAN AB
Citation: Je. Leggat et al., IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 3A IN NORMAL AND NEOPLASTIC KIDNEY AND URINARY-BLADDER EPITHELIUM, The FASEB journal, 9(4), 1995, pp. 965-965
RELATIVE IMPACT OF DONOR-TYPE ON RENAL-ALLOGRAFT SURVIVAL IN BLACK-AND-WHITE RECIPIENTS
Authors: OJO AO PORT FK MAUGER EA WOLFE RA LEICHTMAN AB
Citation: Ao. Ojo et al., RELATIVE IMPACT OF DONOR-TYPE ON RENAL-ALLOGRAFT SURVIVAL IN BLACK-AND-WHITE RECIPIENTS, American journal of kidney diseases, 25(4), 1995, pp. 623-628
INFERIOR OUTCOME OF 2-HAPLOTYPE MATCHED RENAL-TRANSPLANTS IN BLACKS -ROLE OF EARLY REJECTION
Authors: OJO AO PORT FK HELD PJ WOLFE RA TURENNE MN CHUNG E MAUGER EA LEICHTMAN AB
Citation: Ao. Ojo et al., INFERIOR OUTCOME OF 2-HAPLOTYPE MATCHED RENAL-TRANSPLANTS IN BLACKS -ROLE OF EARLY REJECTION, Kidney international, 48(5), 1995, pp. 1592-1599
EVALUATION OF LIVING RENAL DONORS - THE CURRENT PRACTICE OF US TRANSPLANT CENTERS
Authors: BIA MJ RAMOS EL DANOVITCH GM GASTON RS HARMON WE LEICHTMAN AB LUNDIN PA NEYLAN J KASISKE BL
Citation: Mj. Bia et al., EVALUATION OF LIVING RENAL DONORS - THE CURRENT PRACTICE OF US TRANSPLANT CENTERS, Transplantation, 60(4), 1995, pp. 322-327
CASE-REPORT - REVERSAL OF LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION AFTERRENAL-TRANSPLANTATION IN A PATIENT WITH A DIABETIC NEPHROPATHY
Authors: FALCONE RA LEICHTMAN AB MARCOVITZ PA ARMSTRONG WF
Citation: Ra. Falcone et al., CASE-REPORT - REVERSAL OF LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION AFTERRENAL-TRANSPLANTATION IN A PATIENT WITH A DIABETIC NEPHROPATHY, Transplantation, 59(8), 1995, pp. 1215-1217
USEFULNESS OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN DETECTING CORONARY-ARTERY DISEASE IN END-STAGE RENAL-DISEASE
Authors: REIS G MARCOVITZ PA LEICHTMAN AB MERION RM FAY WP WERNS SW ARMSTRONG WF
Citation: G. Reis et al., USEFULNESS OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN DETECTING CORONARY-ARTERY DISEASE IN END-STAGE RENAL-DISEASE, The American journal of cardiology, 75(10), 1995, pp. 707-710
IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 3A IN NORMAL AND NEOPLASTIC KIDNEY AND URINARY-BLADDER EPITHELIUM
Authors: LEGGAT JE JOHNSON KJ KOLARS JC SCHMIEDLINREN P WATKINS PB LEICHTMAN AB
Citation: Je. Leggat et al., IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 3A IN NORMAL AND NEOPLASTIC KIDNEY AND URINARY-BLADDER EPITHELIUM, Journal of the American Society of Nephrology, 5(3), 1994, pp. 786-786
A PROSPECTIVE-STUDY OF RENAL STRUCTURE AND FUNCTION IN PSORIASIS PATIENTS TREATED WITH CYCLOSPORINE
Authors: YOUNG EW ELLIS CN MESSANA JM JOHNSON KJ LEICHTMAN AB MIHATSCH MJ HAMILTON TA GROISSER DS FRADIN MS VOORHEES JJ
Citation: Ew. Young et al., A PROSPECTIVE-STUDY OF RENAL STRUCTURE AND FUNCTION IN PSORIASIS PATIENTS TREATED WITH CYCLOSPORINE, Kidney international, 46(4), 1994, pp. 1216-1222
BIOTRANSFORMATION OF CYCLOSPORINE-G IN COMPARISON TO CYCLOSPORINE (VOL 26, PG 3013, 1994)
Authors: MANGOLD JB SCHRAN HF YATSCHOFF RW WEITZEL WF LEICHTMAN AB
Citation: Jb. Mangold et al., BIOTRANSFORMATION OF CYCLOSPORINE-G IN COMPARISON TO CYCLOSPORINE (VOL 26, PG 3013, 1994), Transplantation proceedings, 26(6), 1994, pp. 3741-3741
BIOTRANSFORMATION OF CYCLOSPORINE-G IN COMPARISON TO CYCLOSPORINE
Authors: MANGOLD JB SCHRAN HF YATSCOFF RW WEITZEL WF LEICHTMAN AB
Citation: Jb. Mangold et al., BIOTRANSFORMATION OF CYCLOSPORINE-G IN COMPARISON TO CYCLOSPORINE, Transplantation proceedings, 26(5), 1994, pp. 3013-3016
PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG-37-325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST - A PROSPECTIVE-STUDY IN RENAL-TRANSPLANT RECIPIENTS
Authors: TURGEON DK LEICHTMAN AB BLAKE DS SCHMOUDER RL LOWN KS ANNESLEY TM WATKINS PB
Citation: Dk. Turgeon et al., PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG-37-325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST - A PROSPECTIVE-STUDY IN RENAL-TRANSPLANT RECIPIENTS, Transplantation, 57(12), 1994, pp. 1736-1741
P450 3A ACTIVITY AND CYCLOSPORINE DOSING IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS
Authors: TURGEON DK LEICHTMAN AB LOWN KS NORMOLLE DP DEEB GM MERION RM WATKINS PB
Citation: Dk. Turgeon et al., P450 3A ACTIVITY AND CYCLOSPORINE DOSING IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS, Clinical pharmacology and therapeutics, 56(3), 1994, pp. 253-260
STEADY-STATE CONCENTRATION OF CYCLOSPORINE-G (OG37-325) AND ITS METABOLITES IN RENAL-TRANSPLANT RECIPIENTS
Authors: LANGMAN LJ LEICHTMAN AB WEITZEL WF YATSCOFF RW
Citation: Lj. Langman et al., STEADY-STATE CONCENTRATION OF CYCLOSPORINE-G (OG37-325) AND ITS METABOLITES IN RENAL-TRANSPLANT RECIPIENTS, Clinical chemistry, 40(4), 1994, pp. 613-616
Risultati: 1-25 |